163 related articles for article (PubMed ID: 9842415)
1. Proteases and protease inhibitors in cancer.
Van Noorden CJ
Acta Histochem; 1998 Nov; 100(4):344-54. PubMed ID: 9842415
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of deubiquitinating enzyme inhibitors.
Colland F
Biochem Soc Trans; 2010 Feb; 38(Pt 1):137-43. PubMed ID: 20074048
[TBL] [Abstract][Full Text] [Related]
3. Are proteinase inhibitors potentially useful in tumor therapy?
Nelles LP; Schnebli HP
Invasion Metastasis; 1982; 2(2):113-24. PubMed ID: 6203867
[TBL] [Abstract][Full Text] [Related]
4. Role of protease and protease inhibitors in cancer pathogenesis and treatment.
Eatemadi A; Aiyelabegan HT; Negahdari B; Mazlomi MA; Daraee H; Daraee N; Eatemadi R; Sadroddiny E
Biomed Pharmacother; 2017 Feb; 86():221-231. PubMed ID: 28006747
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitors: role and potential therapeutic use in human cancer.
DeClerck YA; Imren S
Eur J Cancer; 1994; 30A(14):2170-80. PubMed ID: 7857719
[TBL] [Abstract][Full Text] [Related]
6. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
Fröhlich E
Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
[No Abstract] [Full Text] [Related]
7. [Antiproteases in the pathogenesis of neoplastic diseases].
Dabrowska M
Przegl Lek; 1998; 55(9):475-9. PubMed ID: 10085727
[TBL] [Abstract][Full Text] [Related]
8. Proteases--structures, mechanism and inhibitors.
Powers JC; Odake S; Oleksyszyn J; Hori H; Ueda T; Boduszek B; Kam C
Agents Actions Suppl; 1993; 42():3-18. PubMed ID: 8356929
[TBL] [Abstract][Full Text] [Related]
9. Biologists take degrading route to tackle cancer.
Abbott A
Nature; 2004 Jun; 429(6994):794. PubMed ID: 15215827
[No Abstract] [Full Text] [Related]
10. Irreversible inhibitors of serine, cysteine, and threonine proteases.
Powers JC; Asgian JL; Ekici OD; James KE
Chem Rev; 2002 Dec; 102(12):4639-750. PubMed ID: 12475205
[No Abstract] [Full Text] [Related]
11. [The role of proteolytic enzymes and their inhibitors in malignant neoplasm invasion (literature review)].
Oglovlina OG; Aref'eva TI
Biokhimiia; 1994 Mar; 59(3):340-52. PubMed ID: 8180267
[TBL] [Abstract][Full Text] [Related]
12. Engineering of proteases and protease inhibition.
Storer AC
Curr Opin Biotechnol; 1991 Aug; 2(4):606-13. PubMed ID: 1367681
[TBL] [Abstract][Full Text] [Related]
13. The potential for proteinase inhibition in cancer treatment.
Dodwell DJ; Howell A
Cancer Treat Rev; 1993 Jul; 19(3):283-96. PubMed ID: 8334678
[No Abstract] [Full Text] [Related]
14. Mechanism and Inhibition of Rhomboid Proteases.
Strisovsky K
Methods Enzymol; 2017; 584():279-293. PubMed ID: 28065267
[TBL] [Abstract][Full Text] [Related]
15. Proteases as anti-cancer targets--molecular and biological basis for development of inhibitor-like drugs against cancer.
Białas A; Kafarski P
Anticancer Agents Med Chem; 2009 Sep; 9(7):728-62. PubMed ID: 19538170
[TBL] [Abstract][Full Text] [Related]
16. Extracellular proteases as targets for treatment of cancer metastases.
Lee M; Fridman R; Mobashery S
Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
[TBL] [Abstract][Full Text] [Related]
17. [Proteases and protease inhibitors in the treatment of cancer].
Brünner NA
Ugeskr Laeger; 1999 Mar; 161(11):1577-80. PubMed ID: 10202439
[No Abstract] [Full Text] [Related]
18. Proteinase inhibition in invasive cancer therapy: four control levels of matrix degradation.
Opdenakker G; Paemen L; Norga K; Masure S
Int J Cancer; 1997 Mar; 70(5):628-30. PubMed ID: 9052766
[No Abstract] [Full Text] [Related]
19. Proteinase-protein inhibitor interaction.
Bode W; Huber R
Biomed Biochim Acta; 1991; 50(4-6):437-46. PubMed ID: 1801707
[TBL] [Abstract][Full Text] [Related]
20. The proteinases in shock.
Schlag G; Redl H
Resuscitation; 1986 Sep; 14(1-2):3-21. PubMed ID: 3024277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
